首页 > 最新文献

Nephrology and Dialysis最新文献

英文 中文
Kidney involvement in the Townes-Brocks syndrome. Literature review and clinical observation 汤恩斯-布罗克斯综合征的肾脏受累。文献复习及临床观察
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-1-102-110
A. Khokhlova, V. Obukhova, V. Dlin
{"title":"Kidney involvement in the Townes-Brocks syndrome. Literature review and clinical observation","authors":"A. Khokhlova, V. Obukhova, V. Dlin","doi":"10.28996/2618-9801-2023-1-102-110","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-1-102-110","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 in patients with advanced stages of diabetic kidney disease: new onset renal replacement therapy as one of the predictors of adverse outcome 晚期糖尿病肾病患者的COVID-19:新发肾脏替代治疗作为不良预后的预测因素之一
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-1-57-75
N. Klochkova, M. Lysenko, E. Zeltyn-Abramov, T. Markova, N. Poteshkina, N. Belavina, S. Kondrashkina
Background: patients with Diabetes Mellitus 2 (DM2) and advanced stages of Diabetic Kidney Disease (DKD) are at high risk for the lethal outcome of COVID-19. The causes of high mortality and the prognostic signifi cance of the new onset of renal replacement therapy (hemodialysis de novo, HD de novo) among these patients are still points of debate. Aim: the identifi cation of risk factors (RF) of lethal outcome in patients with DKD 4-5D stages and evaluation of the prognostic value of HD de novo in patients not receiving HD at the time of hospital admission. Methods: the patients with COVID-19 and advanced stages of DKD were included in a retrospective observational study from 04.01. to 10.30.2020. The endpoints were the outcome of hospitalization (discharge/death) and HD de novo initiation during the inpatient course. Several demographic, DM2, DKD, and COVID-19-associated signs and laboratory parameters were analyzed as independent variables. The subgroup of patients with HD de novo was selected from the general cohort. Results: 120 patients with DKD 4-5D stages were included, with a mean age of 69±10 y, females - 52%. Initially, the observation cohort was divided into subgroups: DKD 4-5 and DKD 5D on maintenance hemodialysis (MHD). The mortality among patients with DKD 4-5 was comparable with the patients on MHD (38,2% vs 38,5%, р=0,975). The independent predictors of lethal outcome in group DKD 4-5 were: age ≥65 y (OR 12,30;95% CI 1,40-33,5;р=0,009), initial prandial glycemia ≥10 mmol/l (OR 14,5;95% CI 3,7-55,4;р<0,001), albuminemia at admission ≤35 g/l (OR 5,17;95% CI 1,52-17,50;р=0,012), Charlson comorbidity index (CCI) ≥10 (OR 6,69;95% CI 1,95-23,00;р=0,002), News2 >4 at admission (OR 7,58;95% CI 2,18-26,37;р=0,001), lung damage CT 3-4 at admission (OR 3,39;95% CI 1,09-10,58;р=0,031). In subgroup DKD 5D the independent predictors of lethal outcome were prandial glycemia at admission ≥10 mmol/l (OR 28,5;95% CI 7,1-33,5;р<0,001), lung damage at admission CT 3-4 (OR 8,35;95% CI 2,64-26,40;р<0,001), CCI ≥10 (OR 6,00;95% CI 1,62-22,16;р=0,006). To determine the risk of lethal outcome predictive models were created using identifi ed risk factors and variables. The predictive value for DKD 4-5 group was 93%, and for DKD 5D was 88%. The assessment of the overall predictive value of these models was carried out using ROC analysis. The mortality among patients with DKD 4-5 without HD de novo was 21,6% vs 72,2% in patients with initiated HD de novo (р<0,001). The independent predictors of HD de novo during the inpatient course were: prandial glycemia at admission ≥10 mmol/l (OR 3,38;95% CI 1,04-10,98;р=0,050), albuminemia at admission ≤35 г/л (OR 3,41;95% CI 1,00-11,55;р=0,050), News2 >4 at admission (OR 5,60;95% CI 1,67-19,47;р=0,006), eGFR ≤20 ml/min/1,73 m2 at admission (OR 4,24;95% CI 1,29-13,99;р=0,020). HD de novo was identifi ed as an independent predictor of adverse outcomes (OR 9,42;95% CI 2,58-34,4;р=0,001). The analysis of cumulative surviva
背景:2型糖尿病(DM2)和晚期糖尿病肾病(DKD)患者发生COVID-19致死结局的风险较高。在这些患者中,高死亡率的原因和新开始的肾脏替代治疗(血液透析,HD de novo)的预后意义仍然是争论的焦点。目的:确定DKD 4-5D期患者致死性结局的危险因素(RF),并评估入院时未接受HD治疗的HD新生患者的预后价值。方法:自2001年4月4日起,对新冠肺炎合并晚期DKD患者进行回顾性观察研究。10.30.2020。终点是住院(出院/死亡)和住院期间HD从头开始的结果。将一些人口统计学、DM2、DKD和covid -19相关体征和实验室参数作为自变量进行分析。新发HD患者亚组选自普通队列。结果:纳入DKD 4 ~ 5d期患者120例,平均年龄69±10岁,女性占52%。最初,观察队列被分为亚组:维持血液透析(MHD)的DKD 4-5和DKD 5D。DKD 4-5患者的死亡率与MHD患者相当(38.2% vs 38.5%, p = 0.975)。DKD 4-5组致死性结局的独立预测因子为:年龄≥65岁(OR 12,30;95% CI 1,40-33,5; r =0,009),初始膳食血糖≥10 mmol/l (OR 14,5;95% CI 3,7-55,4;入院时0.004 (OR 7,58;95% CI 2,18-26,37; r =0,001),入院时肺损伤CT 3-4 (OR 3,39;95% CI 1,09-10,58; r =0,031)。在DKD 5D亚组中,致死结局的独立预测因子为入院时膳食血糖≥10 mmol/l (OR为28.5;95% CI为7,1-33,5;入院时0.004 (OR为5.60;95% CI为1,67-19,47;r = 0.006),入院时eGFR≤20 ml/min/1,73 m2 (OR为4,24;95% CI为1,29-13,99;r = 0.020)。新发HD被认为是不良结局的独立预测因子(OR 9,42;95% CI 2,58-34,4; r =0,001)。累积生存分析显示,DKD 4-5无HD新生组和DKD 5D组的结果相当。新发HD亚组的累计55天生存率仅为10%。结论:是否需要重新开始HD治疗是晚期DKD患者COVID-19不良结局的最有力预测因素之一。DKD 4-5组和DKD 5D组的死亡率相当,这是由于新发HD亚组的死亡率极高。严格控制和纠正HD新生危险因素可使其变为可改变的危险因素,从而改善晚期DKD患者的生存预后。©2023 JSC Vidal Rus。版权所有。
{"title":"COVID-19 in patients with advanced stages of diabetic kidney disease: new onset renal replacement therapy as one of the predictors of adverse outcome","authors":"N. Klochkova, M. Lysenko, E. Zeltyn-Abramov, T. Markova, N. Poteshkina, N. Belavina, S. Kondrashkina","doi":"10.28996/2618-9801-2023-1-57-75","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-1-57-75","url":null,"abstract":"Background: patients with Diabetes Mellitus 2 (DM2) and advanced stages of Diabetic Kidney Disease (DKD) are at high risk for the lethal outcome of COVID-19. The causes of high mortality and the prognostic signifi cance of the new onset of renal replacement therapy (hemodialysis de novo, HD de novo) among these patients are still points of debate. Aim: the identifi cation of risk factors (RF) of lethal outcome in patients with DKD 4-5D stages and evaluation of the prognostic value of HD de novo in patients not receiving HD at the time of hospital admission. Methods: the patients with COVID-19 and advanced stages of DKD were included in a retrospective observational study from 04.01. to 10.30.2020. The endpoints were the outcome of hospitalization (discharge/death) and HD de novo initiation during the inpatient course. Several demographic, DM2, DKD, and COVID-19-associated signs and laboratory parameters were analyzed as independent variables. The subgroup of patients with HD de novo was selected from the general cohort. Results: 120 patients with DKD 4-5D stages were included, with a mean age of 69±10 y, females - 52%. Initially, the observation cohort was divided into subgroups: DKD 4-5 and DKD 5D on maintenance hemodialysis (MHD). The mortality among patients with DKD 4-5 was comparable with the patients on MHD (38,2% vs 38,5%, р=0,975). The independent predictors of lethal outcome in group DKD 4-5 were: age ≥65 y (OR 12,30;95% CI 1,40-33,5;р=0,009), initial prandial glycemia ≥10 mmol/l (OR 14,5;95% CI 3,7-55,4;р<0,001), albuminemia at admission ≤35 g/l (OR 5,17;95% CI 1,52-17,50;р=0,012), Charlson comorbidity index (CCI) ≥10 (OR 6,69;95% CI 1,95-23,00;р=0,002), News2 >4 at admission (OR 7,58;95% CI 2,18-26,37;р=0,001), lung damage CT 3-4 at admission (OR 3,39;95% CI 1,09-10,58;р=0,031). In subgroup DKD 5D the independent predictors of lethal outcome were prandial glycemia at admission ≥10 mmol/l (OR 28,5;95% CI 7,1-33,5;р<0,001), lung damage at admission CT 3-4 (OR 8,35;95% CI 2,64-26,40;р<0,001), CCI ≥10 (OR 6,00;95% CI 1,62-22,16;р=0,006). To determine the risk of lethal outcome predictive models were created using identifi ed risk factors and variables. The predictive value for DKD 4-5 group was 93%, and for DKD 5D was 88%. The assessment of the overall predictive value of these models was carried out using ROC analysis. The mortality among patients with DKD 4-5 without HD de novo was 21,6% vs 72,2% in patients with initiated HD de novo (р<0,001). The independent predictors of HD de novo during the inpatient course were: prandial glycemia at admission ≥10 mmol/l (OR 3,38;95% CI 1,04-10,98;р=0,050), albuminemia at admission ≤35 г/л (OR 3,41;95% CI 1,00-11,55;р=0,050), News2 >4 at admission (OR 5,60;95% CI 1,67-19,47;р=0,006), eGFR ≤20 ml/min/1,73 m2 at admission (OR 4,24;95% CI 1,29-13,99;р=0,020). HD de novo was identifi ed as an independent predictor of adverse outcomes (OR 9,42;95% CI 2,58-34,4;р=0,001). The analysis of cumulative surviva","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Secondary hyperparathyroidism. Specific features, complexity, features of treatment. Literature review. Part I 继发性甲状旁腺功能亢进。具体的特点,复杂性,特点的处理。文献综述。第一部分
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-2-222-231
A. Shabunin, E. Shutov, D. Dolidze, E. Zakharova, D. Slepukhova, S. Covantsev, S. A. Bolshakov
{"title":"Secondary hyperparathyroidism. Specific features, complexity, features of treatment. Literature review. Part I","authors":"A. Shabunin, E. Shutov, D. Dolidze, E. Zakharova, D. Slepukhova, S. Covantsev, S. A. Bolshakov","doi":"10.28996/2618-9801-2023-2-222-231","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-2-222-231","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy in chronic kidney disease stage 4: a case series from a referral center 慢性肾脏疾病4期妊娠:来自转诊中心的病例系列
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-2-284-293
K. Demyanova, N. Kozlovskaya, E. Zakharova, Y. Korotchaeva, S. Apresyan, M. Vorobyeva, G. Piccoli
{"title":"Pregnancy in chronic kidney disease stage 4: a case series from a referral center","authors":"K. Demyanova, N. Kozlovskaya, E. Zakharova, Y. Korotchaeva, S. Apresyan, M. Vorobyeva, G. Piccoli","doi":"10.28996/2618-9801-2023-2-284-293","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-2-284-293","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of fatal severe chickenpox in a patient with a kidney transplant 肾移植患者发生致命严重水痘病例
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-2-303-312
N. Frolova, R. F. Sayfullin, L.Y. Artukhina, I.G. Maymasov, E.A. Kalugin, R. Ishakov, E.S. Bukhantsova, O. Y. Evsyukov
{"title":"A case of fatal severe chickenpox in a patient with a kidney transplant","authors":"N. Frolova, R. F. Sayfullin, L.Y. Artukhina, I.G. Maymasov, E.A. Kalugin, R. Ishakov, E.S. Bukhantsova, O. Y. Evsyukov","doi":"10.28996/2618-9801-2023-2-303-312","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-2-303-312","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperparathyroidism and chronic kidney disease. Part 2. Modern approaches to the prevention and treatment of secondary hyperparathyroidism. Lecture 甲状旁腺功能亢进和慢性肾病。第2部分。继发性甲状旁腺功能亢进的现代预防和治疗方法。讲座
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-3-360-382
O.N. Vetchinnikova
{"title":"Hyperparathyroidism and chronic kidney disease. Part 2. Modern approaches to the prevention and treatment of secondary hyperparathyroidism. Lecture","authors":"O.N. Vetchinnikova","doi":"10.28996/2618-9801-2023-3-360-382","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-3-360-382","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135955058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and morphological features of ANCA-associated glomerulonephritis anca相关性肾小球肾炎的临床及形态学特征
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-2-275-283
G. Postnikova, O. Simonova, E. Stolyarevich
{"title":"Clinical and morphological features of ANCA-associated glomerulonephritis","authors":"G. Postnikova, O. Simonova, E. Stolyarevich","doi":"10.28996/2618-9801-2023-2-275-283","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-2-275-283","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C3 glomerulopathy: a long way from the light microscopy findings to the targeted therapy C3肾小球病变:从光镜发现到靶向治疗还有很长的路要走
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-3-345-359
E.V. Zakharova, A.S. Zykova
{"title":"C3 glomerulopathy: a long way from the light microscopy findings to the targeted therapy","authors":"E.V. Zakharova, A.S. Zykova","doi":"10.28996/2618-9801-2023-3-345-359","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-3-345-359","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135955064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transluminal balloon angioplasty in the treatment of central vein stenoses and arteriovenous fistulas: immediate and long-term results 经腔内球囊血管成形术治疗中心静脉狭窄和动静脉瘘:近期和远期效果
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-1-89-97
A. Shabunin, P. Drozdov, D. A. Makeev, I. Nesterenko, O. S. Zhuravel, S. А. Astapovich, E. Lidzhieva
{"title":"Transluminal balloon angioplasty in the treatment of central vein stenoses and arteriovenous fistulas: immediate and long-term results","authors":"A. Shabunin, P. Drozdov, D. A. Makeev, I. Nesterenko, O. S. Zhuravel, S. А. Astapovich, E. Lidzhieva","doi":"10.28996/2618-9801-2023-1-89-97","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-1-89-97","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive surgery of renal cell carcinoma of a transplanted kidney Clinical case 移植肾肾细胞癌的微创手术治疗
Pub Date : 2023-01-01 DOI: 10.28996/2618-9801-2023-1-98-101
{"title":"Minimally invasive surgery of renal cell carcinoma of a transplanted kidney Clinical case","authors":"","doi":"10.28996/2618-9801-2023-1-98-101","DOIUrl":"https://doi.org/10.28996/2618-9801-2023-1-98-101","url":null,"abstract":"","PeriodicalId":52208,"journal":{"name":"Nephrology and Dialysis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69403396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nephrology and Dialysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1